Gossamer Bio Long Term Deferred Charges (Quarterly) Insights

Gossamer Bio, Inc. (GOSS)

2.13 +0.02 (+0.95%) USD | NASDAQ | Feb 20, 16:00

2.13 0.00 (0.00%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for GOSS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Madrigal Pharmaceuticals, Inc.	--
XOMA Royalty Corp.	--
Rezolute, Inc.	--
Axsome Therapeutics, Inc.	--
Crinetics Pharmaceuticals, Inc.	--